Posterior Circulation Ischemic Vertigo
Conditions
Interventions
Control group:The control group was given aspirin enteric coated tablets (Bayer Medical and Health Co., Ltd., national drug approval number J20171021100 mg/tablet), with 1 tablet taken orally daily
Resuvastatin calcium tablets (AstraZeneca Pharmaceutical Co., Ltd., National Drug Approval J20120006, 10mg/tablet), taken orally once a night. Give symptomatic treatment to improve circulation and diz
Low-dose group:On the basis of the control group, the low-dose group received oral administration of Shenxiang Suhe Pills (Hangzhou Hu Qingyutang, National Medicine Approval Z33020141, 0.7g/bottle, 2
High-dose group:On the basis of the control group, the high-dose group received oral administration of Shenxiang Suhe Pills at a dose of 0.7g, once daily in the morning and evening.
Sponsors
Zhejiang Provincial Tongde Hospital
Eligibility
Sex/Gender
All
Age
40 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1) Age: 40-85 years old; 2) Conforming to symptoms of posterior circulation ischemic dizziness; 3) TCD indicates abnormal hemodynamics of the vertebral basilar artery system; 4) Color Doppler ultrasound confirmed the existence of atherosclerotic plaque, lumen stenosis and occlusion in the vertebrobasilar artery system; 5) Head CT with/without brainstem, cerebellar, and occipital lobe infarction; 6) The patient or family member signs an informed consent form.
Exclusion criteria
Exclusion criteria: 1) Head CT indicates cerebral hemorrhage; 2) Severe liver and kidney function damage; 3) Malignant tumors; 4) Individuals with mental symptoms who are unable to cooperate.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Transcranial doppler; | — |
Secondary
| Measure | Time frame |
|---|---|
| Plasma viscosity;Total cholesterol;Low density lipoprotein cholesterol;High-density lipoprotein cholesterol;Triglyceride;CRP;Evaluation of dizziness efficacy;Scoring of Traditional Chinese Medicine Symptoms; | — |
Countries
China
Contacts
Public ContactLin Xu
Zhejiang Provincial Tongde Hospital
Outcome results
None listed